Eppendorf striving to ensure all labs are smart, safe, and stress-free, with Eppendorf Advantage
A range of best-in-class solutions that drive productivity in the laboratory.
Eppendorf has announced the latest Advantage promotion period, until 31 December 2016, on a range of best-in-class solutions that drive productivity in the laboratory. With sample safety, intuitive functionality, and reliability in mind, Eppendorf offers solutions that support a smart, safe, and stress-free environment for researchers across the life sciences industry.
For many research labs, handling hazardous liquids, such as foaming, viscous, volatile, dense, corrosive or hazardous solutions, can be challenging, particularly when the properties of these liquids can affect, and impair, the accuracy and reproducibility of results. The Advantage range includes, the ergonomically designed Multipette M4, with positive displacement, and Combitips advanced, which can eliminate these associated challenges. The Multipette M4 offers a unique volume range, 1 µL–10 µL, and can accommodate 9 Combitips advanced sizes from 0.1 to 50 mL. In addition, automatic Combitip recognition, combined with the ability to conduct 100 dispensing steps, without the need for refilling the tip, ensures fast, precise, and contamination-free dispensing.
Steve Dey, Marketing Director, Eppendorf UK Limited commented: “We at Eppendorf are always striving to be the expert partner in life science laboratories. As one of the industry's technology leaders, we have set industry standards time and again over past decades and always look to the future to contribute to making repetitive laboratory workflows simple, precise, safe and efficient. Eppendorf Advantage is an opportunity for those working across life sciences to optimise their laboratory productivity.”
Additional solutions for researchers and technicians to take advantage of include the Eppendorf ThermoMixer C; with quick and easy-to-exchange SmartBlocks for common lab vessel and plate formats from 5 µL to 50 µL, it is ideally suited to applications such as plasmid/RNA/DNA purification, cDNA synthesis, bacterial growth and lysis reactions at 100 °C. Researchers can expect consistently dependable and reproducible assay results due to outstanding mixing performance, with 2DMix-Control, and exceptional temperature regulation, meaning samples can be simultaneously mixed and incubated.
Until 31 December, the 24-place Centrifuge 5424, and refrigerated 5424 R, will also be on offer, as part of a Special Value Pack which also includes an 18-place Eppendorf Kit rotor, giving researchers access to state-of-the-art cooling technology, for maximum sample protection. Similarly, researchers can purchase the Innova 44, and 44R incubator shakers, which offer broad temperature capabilities and varying shaking speeds for culturing a wide variety of cell types in flasks up to 5 L.
Researchers and technicians will also be able to purchase the perfect tools for methods in nucleic acids, protein, and turbidity measurements: the Eppendorf BioPhotometer D30 records at fixed wavelengths, clearly processes data volume, and makes evaluating results fast, and simple, whilst the Eppendorf µCuvette G1.0 is ideal for microvolume measurements of highly concentrated samples without prior dilution.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance